Stay updated with the latest weight-management news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on weight-management topics.
Mumbai: Emcure Pharmaceuticals has reduced the price of its weight management drug Poviztra (semaglutide injection) across India by an average of 47% across dosages in a bid to widen patient access. The starting dose price is cut by 55% to Rs 3,999 per month (four weekly doses). The innovator semaglutide is available in a once-weekly pen device in five strengths of 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and a maintenance dose of 2.4 mg with the highest dose priced at Rs 8,999 for a month's supply. Em ...Read More >
New Delhi, Apr 2 (PTI) Emcure Pharmaceuticals on Thursday announced a reduction in the price of its weight management drug, Poviztra, a semaglutide injection, by up to 55 per cent to expand patient access. The starting dose of Poviztra (0.25 mg) will now be available at Rs 3,999 per month (inclusive of taxes), a reduction of 55 per cent from the previous price of Rs 8,790, with the price reduction effective from April 3, 2026. Across all doses, the price of Poviztra has been reduced by an aver ...Read More >
New Delhi, Dec 15 (PTI) Biocon Ltd on Monday said it has launched its diabetes and chronic weight management injection, Liraglutide, in the Netherlands through its distribution partner, Pharmamedic BV. The drug-device combination will be marketed in the Netherlands under the brand names Diavorin for diabetes and Vobexoryn for chronic weight management, Biocon said in a statement. Liraglutide is a synthetic analog of GLP-1 peptide (glucagon-like peptide-1) that helps lower blood sugar levels an ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.